2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole

C204H122N26O3 — CID 157246148

IUPAC2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccn%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)nc1.c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9ccc(-c%10nc(-c%11ccccc%11)c%11ccccc%11n%10)cc9)c8c7)o6)cc54)cc3)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1
InChIInChI=1S/C74H44N8O.C66H40N8O.C64H38N10O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-15-41(16-4-1)61-53-21-7-11-23-55(53)67-63(69-61)43-27-33-47(34-28-43)73-57-25-13-9-19-49(57)51-37-31-45(39-59(51)73)65-71-72-66(75-65)46-32-38-52-50-20-10-14-26-58(50)74(60(52)40-46)48-35-29-44(30-36-48)64-68-56-24-12-8-22-54(56)62(70-64)42-17-5-2-6-18-42;1-5-19-53-49(15-1)59(41-27-23-39(24-28-41)51-17-9-11-35-65-51)69-63(67-53)73-55-21-7-3-13-45(55)47-33-31-43(37-57(47)73)61-71-72-62(75-61)44-32-34-48-46-14-4-8-22-56(46)74(58(48)38-44)64-68-54-20-6-2-16-50(54)60(70-64)42-29-25-40(26-30-42)52-18-10-12-36-66-52/h1-44H;1-40H;1-38H
InChIKeyAVUFPYNHNOGJDY-UHFFFAOYSA-N
MW2985.40 g/mol
LogP49.55
Rot. Bonds24

About 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole

2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole (PubChem CID 157246148) has the molecular formula C204H122N26O3 and a molecular weight of 2985.40 g/mol. Its IUPAC name is 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole
PubChem CID157246148
Molecular FormulaC204H122N26O3
Molecular Weight2985.40 g/mol
Exact Mass2983.02
IUPAC Name2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccn%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)nc1.c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9ccc(-c%10nc(-c%11ccccc%11)c%11ccccc%11n%10)cc9)c8c7)o6)cc54)cc3)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1
InChIInChI=1S/C74H44N8O.C66H40N8O.C64H38N10O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-15-41(16-4-1)61-53-21-7-11-23-55(53)67-63(69-61)43-27-33-47(34-28-43)73-57-25-13-9-19-49(57)51-37-31-45(39-59(51)73)65-71-72-66(75-65)46-32-38-52-50-20-10-14-26-58(50)74(60(52)40-46)48-35-29-44(30-36-48)64-68-56-24-12-8-22-54(56)62(70-64)42-17-5-2-6-18-42;1-5-19-53-49(15-1)59(41-27-23-39(24-28-41)51-17-9-11-35-65-51)69-63(67-53)73-55-21-7-3-13-45(55)47-33-31-43(37-57(47)73)61-71-72-62(75-61)44-32-34-48-46-14-4-8-22-56(46)74(58(48)38-44)64-68-54-20-6-2-16-50(54)60(70-64)42-29-25-40(26-30-42)52-18-10-12-36-66-52/h1-44H;1-40H;1-38H
InChIKeyAVUFPYNHNOGJDY-UHFFFAOYSA-N
XLogP49.55
TPSA326.80 Ų
H-Bond Donors
H-Bond Acceptors29
Rotatable Bonds24
Heavy Atoms233
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002985.40
LogP ≤ 549.55
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1029

Analyze 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157163912
methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]purin-8-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157371199
16-(4-Imidazo[1,2-a]pyrimidin-2-ylphenyl)-9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-[3-methyl-5-(trifluoromethyl)phenyl]-16-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;2-phenyl-5-(9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaen-16-yl)-1,3,4-oxadiazole
CID 158772688
2-[3,5-Bis(5-naphthalen-1-yl-1,3,4-oxadiazol-2-yl)phenyl]-5-naphthalen-1-yl-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-(4-ethylphenyl)-5-(4-phenylphenyl)-1,2,4-triazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole;2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;4,7-diphenyl-1,10-phenanthroline;2-[4-[1,1,1,3,3,3-hexafluoro-2-[4-[5-(4-phenylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]propan-2-yl]phenyl]-5-(4-phenylphenyl)-1,3,4-oxadiazole;4-naphthalen-1-yl-3,5-diphenyl-1,2,4-triazole;9-[4-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]carbazole
CID 160130312
2,7-Bis(4-hexylphenyl)-4,9-diphenylpyrido[2,3-g]quinoline;2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole;2-[3,5-bis[3-phenyl-6-(trifluoromethyl)quinoxalin-2-yl]phenyl]-6-methyl-3-phenylquinoxaline;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(3-methylphenyl)-5-[4-[tris[4-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]phenyl]-1,3,4-oxadiazole
CID 160311315
1-[4,6-Bis(2-methylbenzimidazol-1-yl)-1,3,5-triazin-2-yl]-2-methylbenzimidazole;9-butan-2-ylcarbazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(2,4-difluorobenzene-6-id-1-yl)pyridine;bis(iridium);2-phenylpyridine;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
CID 161135612
5-(4-Tert-butylphenyl)-3-[2-[3-[1-[3-(4,7-diphenyl-1,10-phenanthrolin-1-ium-1-yl)phenyl]benzimidazol-2-yl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-3-phenylbenzimidazol-5-yl]-2-(4-phenylphenyl)-1,3,4-oxadiazol-3-ium
CID 91238558
6-[5-(5-Fluoro-2-methyl-4-pyridinyl)-1,3,4-oxadiazol-2-yl]-1,3,3-trimethylindol-2-one;1,3,3-trimethyl-6-[2-(6-methyl-3-pyridinyl)pyrimidin-5-yl]indol-2-one
CID 118526031
3,3-Dimethyl-6-(4-methylimidazol-1-yl)-1-(2-methylpyrimidin-5-yl)indol-2-one;3,3-dimethyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-1-(2-methylpyrimidin-5-yl)indol-2-one
CID 118611607
2,5-Bis[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-1,3,4-oxadiazole
CID 122593705
2-[9-(4,6-Diphenylpyrimidin-2-yl)carbazol-1-yl]-5-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole
CID 122593723
2-[9-(4,6-Diphenyl-1,3,5-triazin-2-yl)carbazol-1-yl]-5-[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole
CID 122593725

Frequently Asked Questions

What is the IUPAC name of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
The IUPAC name of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole (CID 157246148) is 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole.
What is the SMILES notation for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
The canonical SMILES for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole is c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccn%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)nc1.c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9ccc(-c%10nc(-c%11ccccc%11)c%11ccccc%11n%10)cc9)c8c7)o6)cc54)cc3)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1.
What is the InChIKey of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
The InChIKey is AVUFPYNHNOGJDY-UHFFFAOYSA-N. The full InChI is InChI=1S/C74H44N8O.C66H40N8O.C64H38N10O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-15-41(16-4-1)61-53-21-7-11-23-55(53)67-63(69-61)43-27-33-47(34-28-43)73-57-25-13-9-19-49(57)51-37-31-45(39-59(51)73)65-71-72-66(75-65)46-32-38-52-50-20-10-14-26-58(50)74(60(52)40-46)48-35-29-44(30-36-48)64-68-56-24-12-8-22-54(56)62(70-64)42-17-5-2-6-18-42;1-5-19-53-49(15-1)59(41-27-23-39(24-28-41)51-17-9-11-35-65-51)69-63(67-53)73-55-21-7-3-13-45(55)47-33-31-43(37-57(47)73)61-71-72-62(75-61)44-32-34-48-46-14-4-8-22-56(46)74(58(48)38-44)64-68-54-20-6-2-16-50(54)60(70-64)42-29-25-40(26-30-42)52-18-10-12-36-66-52/h1-44H;1-40H;1-38H.
What are the key properties of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole has a molecular weight of 2985.40 g/mol, XLogP of 49.55, 24 rotatable bonds, 0 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylquinazolin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 157246148), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).